कृपया अन्य खोज का प्रयास करें
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Patrick J. Heron | 51 | 2016 | Independent Chairman of the Board |
Keith R. Leonard | 61 | 2021 | Independent Director |
Kim Papp | - | - | Scientific Advisor |
Mark Lebwohl | - | - | Scientific Advisor |
Joy Rico | - | - | Scientific Advisor |
Matt Zirwas | - | - | Scientific Advisor |
Howard G. Welgus | 70 | 2016 | Director |
Lawrence F. Eichenfield | 64 | - | Scientific Advisor |
Terrie J. Curran | 53 | 2020 | Independent Director |
Sue-Jean Lin | 53 | 2021 | Independent Director |
Neha Krishnamohan | 36 | 2022 | Independent Director |
Todd Franklin Watanabe | 55 | 2016 | President, CEO & Director |
Bhaskar Chaudhuri | 68 | 2016 | Co-Founder & Independent Director |
Halley E. Gilbert | 53 | 2020 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है